Increased Healthcare Expenditure to Create Scope for the US Nanomedicine Market Growth Aspects

Published: May 2021

The US Nanomedicine market is anticipated to grow significantly at a CAGR of 11.0% over the forecast period (2021-2027). The key aspect that drives the growth of the US nanomedicine market is the significant prevalence of CVD and other diseases along with the high healthcare expenditure is primarily contributing to the market growth in the region. According to the Center for Medicare and Medicaid Services, in 2018. It is further expected to reach $6.0 trillion by 2027. The US has the highest healthcare spending across the globe. Hence, the increased healthcare expenditure by the government is likely to create scope for market growth over the forecast period.

Browse the full report description US Nanomedicines Market Size, Share & Trends Analysis Report By Indication Type (Cardiovascular Diseases, Neurological Diseases, Infectious Diseases, Oncological Diseases, Orthopedic Diseases, and Other Diseases (Urological Disease, Ophthalmic Diseases)), and by Application (Drug Delivery, Active Implants, Vaccines, Diagnostic Imaging, Biomaterials, Regenerative Medicines, and Other Applications (Tissue Regeneration)) Forecast, 2021-2027 at https://www.omrglobal.com/industry-reports/us-nanomedicines-market

Further, the US is considered to showcase a higher adoption rate for advanced technology in the medical field and is also considered a hub for R&D activities in the medical sector. The active R&D activities and clinical trials in the US are related to making advancements in the drugs that are projected to boost the growth of the market in the region. Moreover, the country holds the footprints of major market players including 3M Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca Plc., Celgene Corp., Pfizer Inc., Sanofi SA, and Smith & Nephew Plc among others. These players are significantly contributing to the market growth by adopting several strategies. 

Market Coverage

  • Market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- By Indication Type and By Applications
  • Country Covered- The US
  • Competitive Landscape- 3M Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca Plc., Celgene Corp., Pfizer Inc., Sanofi SA, and Smith & Nephew Plc among others

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment dominates the market in base year?
  • Which segment will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

US Nanomedicine Market – Segmentation

By Indication Type

  • Cardiovascular Diseases
  • Neurological Diseases
  • Infectious Diseases
  • Oncological Diseases
  • Orthopedic Diseases
  • Other Diseases (Urological Disease, Ophthalmic Diseases)

By Application

  • Drug Delivery
  • Active Implants
  • Vaccines
  • Diagnostic Imaging
  • Biomaterials
  • Regenerative Medicines
  • Other Applications (Tissue Regeneration)

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-nanomedicines-market